By November 10, 2022 (Investorideas.com Newswire) XPhyto Therapeutics Corp. (XPHY) has announced a name and symbol change to BioNxt Solutions Inc. (BNXT).
Shares will begin trading under the new name and symbol and with a new CUSIP number on November 14, 2022.
Disclosure documents are available at www.thecse.com
Please note that all open orders will be cancelled at the end of business on November 11, 2022. Dealers are reminded to re-enter their orders.
________________________
XPhyto Therapeutics Corp. (XPHY) a annonce un changement de nom et de symbole pour BioNxt Solutions Inc. (BNXT).
Les actions commenceront ? ?tre negociees sous le nouveau nom et le nouveau symbole et avec un nouveau numero CUSIP le 14 novembre 2022.
Les documents d’information sont disponibles sur www.thecse.com
Veuillez noter que toutes les commandes ouvertes seront annulees ? la fin des activites le 11 novembre 2022. Les concessionnaires sont pries de saisir ? nouveau leurs commandes.
If you have any questions or require further information, please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l’information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l’adresse: Listings@thecse.com
Investorideas.com is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more…
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004; the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. http://thecse.com/
More Info:
This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
BiotechIndustryStocks.com – investing ideas in biotechnology stocks, medical technology and life sciences
Like Biotech Stocks? View our Biotech Stocks Directory
